Manning & Napier Group, LLC Novartis Ag Transaction History

Manning & Napier Group, LLC

  • $8.76 Billion
  • Q1 2024

A detailed history of Manning & Napier Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Manning & Napier Group, LLC holds 1,042,426 shares of NVS stock, worth $109 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares
1,042,426
Previous 1,057,168 1.39%
Holding current value
$109 Million
Previous $107 Million 5.54%
% of portfolio
1.15%
Previous 1.27%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024
SELL
$95.27 - $108.47 $1.4 Million - $1.6 Million
-14,742 Reduced 1.39%
1,042,426 $101 Million
Q4 2023

Jan 19, 2024
SELL
$92.27 - $101.54 $1.11 Million - $1.22 Million
-12,025 Reduced 1.12%
1,057,168 $107 Million
Q3 2023

Oct 20, 2023
SELL
$94.73 - $105.13 $1.58 Million - $1.75 Million
-16,638 Reduced 1.53%
1,069,193 $109 Million
Q2 2023

Jul 26, 2023
SELL
$92.52 - $104.91 $62.3 Million - $70.7 Million
-673,799 Reduced 38.29%
1,085,831 $110 Million
Q1 2023

Apr 17, 2023
BUY
$80.03 - $92.81 $122,525 - $142,092
1,531 Added 0.09%
1,759,630 $162 Million
Q4 2022

Jan 26, 2023
SELL
$75.55 - $92.52 $2.46 Million - $3.02 Million
-32,591 Reduced 1.82%
1,758,099 $0
Q3 2022

Oct 18, 2022
SELL
$74.61 - $87.26 $913,450 - $1.07 Million
-12,243 Reduced 0.68%
1,790,690 $136 Million
Q2 2022

Jul 12, 2022
SELL
$80.52 - $93.75 $2.66 Million - $3.1 Million
-33,047 Reduced 1.8%
1,802,933 $152 Million
Q1 2022

Apr 19, 2022
SELL
$80.11 - $90.62 $7.39 Million - $8.36 Million
-92,246 Reduced 4.78%
1,835,980 $161 Million
Q4 2021

Jan 27, 2022
BUY
$79.7 - $88.13 $1.45 Million - $1.61 Million
18,232 Added 0.95%
1,928,226 $169 Million
Q3 2021

Oct 14, 2021
BUY
$81.78 - $95.14 $2.1 Million - $2.44 Million
25,665 Added 1.36%
1,909,994 $156 Million
Q2 2021

Jul 19, 2021
BUY
$85.24 - $94.15 $13.1 Million - $14.5 Million
153,982 Added 8.9%
1,884,329 $172 Million
Q1 2021

Apr 28, 2021
SELL
$83.5 - $98.47 $34.1 Million - $40.2 Million
-407,958 Reduced 19.08%
1,730,347 $148 Million
Q4 2020

Jan 20, 2021
SELL
$78.07 - $94.43 $4.06 Million - $4.92 Million
-52,060 Reduced 2.38%
2,138,305 $202 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $5.11 Million - $5.66 Million
62,239 Added 2.92%
2,190,365 $190 Million
Q2 2020

Jul 10, 2020
SELL
$80.93 - $91.1 $7.32 Million - $8.25 Million
-90,509 Reduced 4.08%
2,128,126 $186 Million
Q1 2020

Apr 13, 2020
BUY
$70.67 - $99.01 $4.16 Million - $5.83 Million
58,901 Added 2.73%
2,218,635 $183 Million
Q4 2019

Jan 10, 2020
SELL
$84.35 - $95.37 $21.4 Million - $24.2 Million
-253,817 Reduced 10.52%
2,159,734 $205 Million
Q3 2019

Oct 10, 2019
SELL
$85.54 - $94.26 $7.3 Million - $8.05 Million
-85,376 Reduced 3.42%
2,413,551 $210 Million
Q2 2019

Jul 24, 2019
SELL
$75.4 - $92.8 $57.6 Million - $70.9 Million
-764,533 Reduced 23.43%
2,498,927 $228 Million
Q1 2019

Apr 10, 2019
SELL
$75.32 - $86.15 $11.4 Million - $13.1 Million
-151,747 Reduced 4.44%
3,263,460 $314 Million
Q4 2018

Jan 24, 2019
SELL
$73.66 - $82.02 $5.21 Million - $5.81 Million
-70,797 Reduced 2.03%
3,415,207 $293 Million
Q3 2018

Oct 10, 2018
SELL
$66.94 - $77.43 $13.1 Million - $15.2 Million
-196,031 Reduced 5.32%
3,486,004 $300 Million
Q2 2018

Jul 13, 2018
SELL
$64.91 - $73.36 $4.78 Million - $5.4 Million
-73,628 Reduced 1.96%
3,682,035 $278 Million
Q1 2018

May 01, 2018
SELL
$70.39 - $84.15 $11.6 Million - $13.9 Million
-165,254 Reduced 4.21%
3,755,663 $304 Million
Q4 2017

Feb 05, 2018
BUY
$72.33 - $77.64 $284 Million - $304 Million
3,920,917
3,920,917 $329 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email